65,437 trials
Gingivitis
Primary: Change From Baseline in Modified Gingival Index (MGI) — -0.07; -0.09; -0.09; -0.02 units on a scale
Osteoarthritis of the Knee
Primary: Numeric Rating Scale (NRS) — 43; 11 Participants
Chronic Low Back Pain
Primary: Roland-Morris Disability Questionnaire — -2.05; -1.29 units on a scale — p=0.340
Apnea
Primary: Received Tidal Volume — 662; 681 milliliters — p=0.280
Endometrial Adenocarcinoma · Endometrial Clear Cell Adenocarcinoma · Endometrial Mucinous Adenocarcinoma
Primary: Number of Participants With Adverse Events — 1; 1; 2; 4 Participants
Trachoma
Primary: The Proportion of Communities With C. Trachomatis Infection Prevalence of 1% or Below — 7; 4 community — p=>0.05
Kidney Transplant · Diabetes Mellitus, Type 2 · Diabetic Nephropathy
Primary: Freedom From Insulin Therapy Post Transplant — 3; 4 Participants
Arthritis, Rheumatoid
Primary: Autoinjector Assessment Period: Percentage of Successful Self-injections as Reported in the Questionnaires Completed by Both the Trial Site Personnel and the Patient…
Diabetes · Obesity · Weight Gain
Primary: Mean Weight Change Per Week From Baseline to Termination — 0.133; -0.0756 Pounds per week — p=<.001
Infections, Cytomegalovirus
Primary: Concentrations of Antibodies Against Anti-Glycoprotein B (gB) Immunoglobulin G (IgG) — 5091.4; 5495.1; 2587.2 EL.U/mL
Adverse Drug Events
Primary: Mean Severity-weighted Admission Medication History (AMH) Error Score — 23; 4.1; 4.1 Mean Severity-weighted AMH Error Score
Infections, Streptococcal
Primary: Number of Subjects With Fever > 40.0°C (Rectal Temperature) — 0; 1 Participants
Critical Illness
Primary: Sensitivity and Specificity of Navigator Threshold Alarms for Hypoglycemia (<60 mg/dl).
Prostate Adenocarcinoma · Stage I Prostate Cancer · Stage IIA Prostate Cancer
Primary: Pathologic Complete Response at the Time of Surgery — 10; 8; 0 Participants
Age Related Macular Degeneration
Primary: Mean Change in Visual Acuity (VA) From Baseline at Month 6 — 6.1; 2.0 ETDRS Letters